Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
B12 (hydroxocobalamin) is a prescription-only medicine in the UK and is safest given by, or under the supervision of, a trained clinician
Ipamorelin Description: A gentle growth hormone secretagogue that stimulates growth hormone production for muscle recovery, fat burning, and better sleep
Key selective action features: No Growth Hormone Receptor Binding: Does not activate GH receptors responsible for IGF-1 stimulation and systemic growth effects Preserved Glucose Metabolism: No impact on blood sugar regulation, insulin sensitivity, or diabetic risk markers No Tissue Growth Effects: Does not promote muscle hypertrophy, organ growth, or cell proliferation pathways Adipose-Specific Targeting: Works primarily through beta-3 adrenergic receptors concentrated in fat tissue No IGF-1 Elevation: Clinical trials confirmed no changes in serum IGF-1 levels at therapeutic doses Isolated Lipolytic Action: Maintains the fat-breaking properties of growth hormone fragment 176-191 without broader effects Selective Mechanism: Structural differences from full-length GH prevent binding to receptors mediating non-fat-related effects Clinical Validation: Human studies in 900+ participants confirmed selective fat metabolism without systemic hormonal changes The following guide provides detailed analysis of AOD-9604 s selective action and why this selectivity matters for safe, targeted fat metabolism
Growth hormone peptides such as CJC-1295, Ipamorelin, Sermorelin, and Tesamorelin prompt the pituitary to release more of the bodys own growth hormone
Pen Dosage Chart Dosage & Protocols Variations Standard Research Protocol Dose: 0.3 1.2 mg (= 1248 clicks) Duration: 8 12 weeks Frequency: Once weekly Cycle Interval: 4 weeks off before repeating Goal / Description: Baseline protocol for appetite regulation and body weight modulation in experimental models
Drug Discovery & Development
